Thalassemia Treatment with Bone Marrow Transplantation - Haploidentical (Half) Match | Beijing Jingdu Children's Hospital, China

9.60

Beijing, China

Overview

Age group

Kids

Type of care

Inpatient

Method

Non-surgical

About the offer

For children living with thalassemia, Beijing Jingdu Children’s Hospital provides specialized bone marrow transplantation services. The optimal transplant window is between 2 and 7 years of age—a golden period characterized by robust post-operative recovery and minimized surgical risks. Patients aged 8 to 18 are also eligible for the procedure. As a leading pediatric hematopoietic stem cell transplantation center with a track record of over 2,000 successful surgeries, we are at the forefront of adopting the proprietary Beijing Protocol for thalassemia treatment, offering new hope to young patients worldwide. Helmed by senior hematology specialists, our medical team further refines the Beijing Protocol to deliver fully personalized treatment plans. We particularly integrate umbilical cord blood transplantation-valued for its stable engraftment and low rejection risk-into our practice. This specialized, patient-centric approach has yielded an impressive 95. 6% success rate, underscoring our exceptional expertise in pediatric thalassemia treatment.

What’s included

Medical service

Examination

Comprehensive pediatric hematology consultation and physical examination
Detailed history review (transfusion frequency, chelation, infections, growth, and development)
Baseline organ assessment focused on transplant readiness (heart, liver, endocrine status, nutrition)
Donor screening visit for a potential haploidentical family donor (typically parent/sibling)

Laboratory tests

Complete blood count (CBC) with reticulocyte count and peripheral smear
Iron overload evaluation: ferritin, liver function tests, and iron studies
Viral screening: Hepatitis B/C, HIV, CMV, EBV (patient and donor)
Blood group typing, antibody screen, and extended RBC phenotyping
HLA typing for haploidentical donor selection and compatibility planning
Bone marrow evaluation as indicated (baseline marrow status and cellularity)
Renal profile, electrolytes, coagulation panel, and inflammatory markers
Genetic confirmation of thalassemia mutation (if not already available)

Diagnosis

Confirmation of thalassemia type and severity (major/intermediate) based on clinical course and genetics
Assessment of transfusion dependence and chelation history
Transplant risk stratification (iron burden, liver status, prior infections, alloimmunization)
Donor eligibility determination for haploidentical transplantation

Treatment

Individualized haploidentical bone marrow transplantation plan at Beijing Jingdu Children’s Hospital
Pre-transplant optimization: iron chelation strategy, infection control, nutrition, and organ support
Conditioning regimen planning (tailored to age, disease severity, and organ function)
Bone marrow stem cell infusion with supportive inpatient transplant care
GVHD prevention and monitoring protocol with close immune and chimerism follow-up
Post-transplant supportive care: antimicrobials, transfusion support as needed, and recovery monitoring
Discharge planning with a structured follow-up schedule and long-term survivorship guidance

Other

Dedicated international patient coordination (admission planning, timelines, required documents)
Treatment cost outline and estimated length of stay shared in advance (case-dependent)
Assistance with medical record review and second-opinion style assessment prior to travel
Language support and care-navigation services for families during hospitalization
Education for caregivers on infection prevention, medication adherence, and warning signs

Distant service

Remote pre-assessment based on medical records (history, transfusion logs, prior labs/imaging)
Online donor suitability guidance and recommended tests to complete locally
Virtual consultation to explain the transplant course, risks, expected outcomes, and aftercare
Post-discharge tele-follow-ups for lab trend review and complication screening (as appropriate)
Coordination with the child’s local physician for shared-care monitoring after returning home

Extra add-ons

Single room

Hospital meals

Personal coordinator

Language Assistance

Visa Support

AiroCare

AiroMedical support

Payment protection

Patient advocacy

Price match

Meet the provider

Beijing Jingdu Children's Hospital

Beijing, China

9.60

Gallery

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

Location

308 Hui Long Guan Dong Da Jie, Chang Ping Qu, Bei Jing Shi, China, 102208

FAQ

What is the cost?

The total price for Thalassemia Treatment with Bone Marrow Transplantation - Haploidentical (Half) Match | Beijing Jingdu Children's Hospital, China is €61,355. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

What is the rating of the offer?

Thalassemia Treatment with Bone Marrow Transplantation - Haploidentical (Half) Match | Beijing Jingdu Children's Hospital, China is rated as 9.60 by AiroMedical.